Part 4 of 4:Â
Jon Chee hosts our latest guest, Neela Patel, Chief Business Officer at Bonum Therapeutics who are developing protein therapeutics to be used to treat a wide range of diseases. Neela is a seasoned scientist and business development executive with over 30 years of leadership experience in drug discovery and development.
Before her time at Bonum Therapeutics Neela worked as the CBO at Good Therapeutics, a biotech company that develops cutting edge protein-based drugs. Her impressive career also includes pivotal roles at Seattle Genetics, AbbVie, Abbott, and Genentech. Her extensive experience as both a scientist and business person give her unique insights you won’t want to miss.Â
Join us this week to hear about:- Neela’s transition from AbbVie to Seattle Genetics and business development
- Her meeting with Good Therapeutics CEO and how it changed her career trajectory
- Her move to Good Therapeutics as Chief Business Development Officer
- Neela’s experience leading Good through its acquisition by Roche, and the importance of strategic deal structuring
- Her current role as CBO of Bonum Therapeutics and focus on developing cytokine therapies for oncology
Please enjoy Jon’s conversation with Neela Patel!
Subscribe to the podcast: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994
Find Our Guest, Neela Patel, at these links:Â https://www.linkedin.com/in/neela-patel-84b144/Â https://bonumtx.com/Â
Find Our Host, Jon Chee, at these links:Â https://www.linkedin.com/in/joncheehttps://www.excedr.com
Excedr Socials & WebsiteLinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/Â
Enriched Notes:
Topics Mentioned:Bonum Therapeutics: https://bonumtx.com/Roche: https://www.roche.com/Seattle Genetics (Pfizer): https://www.seagen.com/who-we-are/historyVivo Capital: https://vivocapital.com/Business Development Roles in the Life Sciences: https://www.excedr.com/resources/business-development-in-the-life-sciencesBiotech Startup Support: https://www.excedr.com/resources-category/biotech-startup-supportBuy-side vs. Sell-Side: https://corporatefinanceinstitute.com/resources/career/ma-buy-side-sell-side/Liquidity Events: https://www.investopedia.com/terms/l/liquidity_event.aspWhat Should Investors & Founders Expect From Each Other? https://www.excedr.com/resources/investor-founder-expectations
People Mentioned:Greg Hageman: https://medicine.utah.edu/faculty/gregory-s-hagemanDiane Hollenbaugh: https://www.linkedin.com/in/diane-hollenbaugh-b826723/John Mulligan: https://www.linkedin.com/in/john-mulligan-ph-d-5aa5a37/
Timestamps: 00:00 Intro02:03 Neela’s motivation to join Good Therapeutics, meeting CEO John Mulligan04:12 Evaluating startup teams and the importance of board alignment07:01 Building trust with the board and John Mulligan’s approach09:24 Structuring the Roche deal for streamlined transition10:46 Good Therapeutics’ culture and team transition to Bonum13:08 Understanding investor motivations and startup priorities14:48 Reflections on shifting from buy-side to sell-side21:46 Bonum’s focus on reducing toxicity in oncology and their clinical pipeline goals27:37 Shout-outs to career mentors and advice for younger self31:02 OutroThe Biotech Startups Podcast gives you a front-row seat to the business
and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.
View all episodes
